Drug profile · INN
ertugliflozin
SEGLUROMET
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ertugliflozin (SEGLUROMET) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ertugliflozin
Brand SEGLUROMET
Route ORAL
Formulation TABLET
ATC code A10BK04
Frequently asked questions
What is ertugliflozin?
ertugliflozin (SEGLUROMET) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ertugliflozin?
SEGLUROMET is a marketed brand name for ertugliflozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ertugliflozin?
ertugliflozin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.